This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive medical device, with a period of performance through January 14, 2025.
DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract award, which is not associated with a set-aside designation, further demonstrates DMS Pharmaceutical Group's role as a key supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare facilities nationwide.
Generated 3/23/25, 12:59 AM